NYSE · Healthcare
Medtronic plc (MDT)
As-reported financials and recent SEC filings for Medtronic plc, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$33.54B
Net income
$4.66B
Net margin
13.9%
Diluted EPS
$3.61
ROE
9.7%
P/E (TTM)
21.5×
Market cap
$102.97B
Debt / equity
0.5×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $33.54B | $32.36B | $31.23B | $31.69B | $30.12B |
| Gross profit | $21.91B | $21.15B | $20.51B | $21.54B | $19.63B |
| Operating income | $5.96B | $5.14B | $5.49B | $5.75B | $4.48B |
| Net income | $4.66B | $3.68B | $3.76B | $5.04B | $3.61B |
| Diluted EPS | $3.61 | $2.76 | $2.82 | $3.73 | $2.66 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →1442026-06-08
View on EDGAR →42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →8-K2026-06-03
View on EDGAR →42026-05-28
View on EDGAR →Go deeper on MDT
Search Medtronic plc’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.